The Icahn School of Medicine at Mount Sinai has launched a neurometabolism program that combines basic science research with a clinic dedicated to the care of patients with brain metabolic diseases. The new core also will be home to intensive collaborative efforts with researchers from around the globe who are committed to working on these rare diseases and other neurological conditions in which metabolism plays a key role.
